A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019.
Kevin M CampbellDavid A SiegelPuja J UmaretiyaShifan DaiAndras A HeczeyPhilip J LupoJeremy M SchrawTrevor D ThompsonMichael E ScheurerJennifer H FosterPublished in: Pediatric blood & cancer (2023)
Neuroblastoma incidence was stable during 2003-2019. Differences in relative survival exist by sex, age, race/ethnicity, and stage; patients who were male, older, non-Hispanic Black, or with distant disease had worse survival. Future studies could seek to assess the upstream factors driving disparities in survival, and evaluate interventions to address inequities and improve survival across all groups.